Castleview Partners’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-187
Closed -$15.3K 597
2024
Q3
$15.3K Buy
187
+57
+44% +$4.4K 0.01% 484
2024
Q2
$11.2K Buy
130
+52
+67% +$4.2K 0.01% 503
2024
Q1
$6.37K Buy
78
+32
+70% +$2.5K ﹤0.01% 589
2023
Q4
$3.05K Buy
+46
New +$3.19K ﹤0.01% 654
2023
Q3
Sell
-613
Closed -$38.7K 710
2023
Q2
$38.7K Buy
+613
New +$35.5K 0.03% 288

Other funds holding HQY

Castleview Partners's HQY Position: Q4 2024 in Review

Castleview Partners sold out of HealthEquity (HQY) in Q4 2024, closing a stake of 187 shares — an estimated $15.3K sold.

Castleview Partners first reported a position in HQY in Q2 2023 and held it in 5 quarters. The position peaked at $38.7K in Q2 2023. 441 funds tracked by Wall St. Rank hold HQY as of Q4 2024.

  • Castleview Partners reported no remaining HealthEquity position as of Q4 2024 after selling out during the quarter.
  • Castleview Partners sold 187 HealthEquity shares in Q4 2024, an estimated $15.3K.
  • Castleview Partners first reported a position in HealthEquity in Q2 2023 and held it in 5 quarters.
  • Castleview Partners's HealthEquity position peaked at $38.7K in Q2 2023.
  • 441 funds tracked by Wall St. Rank held HealthEquity as of Q4 2024.

Based on Castleview Partners's 13F filing for Q4 2024, filed 21 Jan 2025.